期刊文献+

抗磷脂综合征的皮肤表现 被引量:2

Cutaneous manifestations of antiphospholipid syndrome
下载PDF
导出
摘要 抗磷脂综合征是一种以反复动静脉形成、流产、血小板减少及血抗磷脂抗体持续阳性为特征的系统性自身免疫性疾病。该综合征可以累及包括皮肤在内的全身任何器官。临床上皮肤表现可作为其首要症状,多见于网状青斑、Sneddon综合征、白色萎缩、皮肤溃疡坏死、斑状萎缩和Degos病等。掌握抗磷脂综合征的皮肤表现对其早期诊断、及时治疗极为关键。 Antiphospholipid syndrome (APS) is a systemic auto-immune disorder characterised by recurrent arterial and/or venous thrombosis, pregnancy losses, thrombocytopenia and the presence of elevated and persistent levels of antiphospholipid antibodies. It may potentially affect any organ including the skin. Dermatologic manifestations may be the ifrst indication of APS and may be noticeable as livedo reticularis, Sneddon's syndrome, atrophie blanche, skin ulcerations and necrosis, anetoderma, or Degos' disease. Knowledge of the cutaneous manifestations of APS is critical in the early identiifcation and fast treatment of APS patients.
出处 《实用皮肤病学杂志》 2014年第3期207-209,213,共4页 Journal of Practical Dermatology
关键词 抗磷脂综合征 皮肤表现 Antiphospholipid syndrome Cutaneous manifestations
  • 相关文献

参考文献29

  • 1Taraborelli M, Andreoli L, Tincani A. Much more than thrombosis and pregnancy loss: The antiphospholipid syndrome as a "systemic disease" [J]. Best Pratt Res Clin Rheumatol, 2012, 26(1):79-90.
  • 2Rand JH, Wolgast LR. Dos and don'ts in diagnosingantiphospholipid syndrome [J]. Hematology Am Soc Hematol Educ Program, 2012, 2012:455-459.
  • 3谢松洲.抗磷脂赏症候群[J].内科翠嚣,2012,23(5):324-329.
  • 4Franc6s C, Niang S, Laffitte E, et al. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases [J]. Arthritis Rheum, 2005, 52(6): 1785-1793.
  • 5Dean SM. Livedo reticularis and related disorders [J]. Curr Treat Options Cardiovasc Med, 2011,13(2): 179-191.
  • 6Biggioggero M, Meroni PL. The geoepidemiology of the antiphospholipid antibody syndrome [J]. Autoimmun Rev, 2010, 9(5):A299-304.
  • 7Weinstein S, Piette W. Cutaneous manifestations of antiphosph- olipid antibody syndrome [J]. Hematol Oncol Clin North Am, 2008, 22(1): 67-77.
  • 8Toubi E, Krause I, Fraser A, et al. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome [J]. Clin Exp Rheumatol, 2005, 23(4):499-504.
  • 9Cervera R, Conti F, Doria A, et al. Does seronegative antiphospholipid syndrome really exist? [J]. Autoimmun Rev, 2012, 11(8):581-584.
  • 10Aladdin Y, Hamadeh M, Butcher K. The Sneddon syndrome [J]. Arch Neurol, 2008, 65(6):83483-83485.

同被引文献4

  • 1Taraborelli M,Andreoli L,Tincani A. Much more than thrombosis and preg- nancy loss :The antiphospholipid syndrome as a "systenfic disease"[ J ]. Best Pract Res Clin Rheumato1,2012,26( 1 ) :79 -90.
  • 2Franc~s C,Niang S, ,affitte E,et al. Demvatologic manifestations of the an- tiphospholipid syndrome: two hundred col~utive cases [ J ]. Arthritis Rheum,2005,52(6) : 1785 - 1793.
  • 3Cervera R,Tektonidou M,Espinosa G,et al. Task force on catastrophic Aaa- tiphospholipid Syndrome (APS) and non-criteria APS manifestations (I1): thromtxytopenia and skin nmnifeztations [ J ]. Lupus, 2011,20 ( 2 ) : 174 -181.
  • 4马艳玲,董可辉,方瑞乐,张玉梅.Sneddon's综合征[J].中国医刊,2016,51(1):32-36. 被引量:3

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部